P. H. Chapman

417 total citations
12 papers, 317 citations indexed

About

P. H. Chapman is a scholar working on Cancer Research, Neurology and Pharmacology. According to data from OpenAlex, P. H. Chapman has authored 12 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cancer Research, 3 papers in Neurology and 3 papers in Pharmacology. Recurrent topics in P. H. Chapman's work include Carcinogens and Genotoxicity Assessment (4 papers), Pesticide Exposure and Toxicity (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). P. H. Chapman is often cited by papers focused on Carcinogens and Genotoxicity Assessment (4 papers), Pesticide Exposure and Toxicity (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). P. H. Chapman collaborates with scholars based in United Kingdom and United States. P. H. Chapman's co-authors include M. D. Rawlins, Sam Shuster, Christopher S. Ogilvy, Philip A. Routledge, D.M. Davies, David M. Frim, D. Nicholas Bateman, Mark H. Gray, Jeffrey A. Golden and P. Kersey and has published in prestigious journals such as The Lancet, Journal of neurosurgery and British Journal of Dermatology.

In The Last Decade

P. H. Chapman

12 papers receiving 275 citations

Peers

P. H. Chapman
P. H. Chapman
Citations per year, relative to P. H. Chapman P. H. Chapman (= 1×) peers Gürkan Sengoelge

Countries citing papers authored by P. H. Chapman

Since Specialization
Citations

This map shows the geographic impact of P. H. Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. H. Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. H. Chapman more than expected).

Fields of papers citing papers by P. H. Chapman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. H. Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. H. Chapman. The network helps show where P. H. Chapman may publish in the future.

Co-authorship network of co-authors of P. H. Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of P. H. Chapman. A scholar is included among the top collaborators of P. H. Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. H. Chapman. P. H. Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Golden, Jeffrey A., David M. Frim, P. H. Chapman, & Jean Paul Vonsattel. (1994). Marked tissue eosinophilia within organizing chronic subdural hematoma membranes.. PubMed. 13(1). 12–6. 18 indexed citations
2.
Frim, David M., et al.. (1992). Is Intracerebral Schwannoma a Developmental Tumor of Children and Young Adults?. Pediatric Neurosurgery. 18(4). 190–194. 42 indexed citations
3.
Ogilvy, Christopher S., et al.. (1989). Meningioangiomatosis in a patient without von Recklinghausen' disease. Journal of neurosurgery. 70(3). 483–485. 28 indexed citations
4.
Bateman, D. Nicholas, P. H. Chapman, & M. D. Rawlins. (1983). Lack of effect of astemizole on ethanol dynamics or kinetics. European Journal of Clinical Pharmacology. 25(4). 567–568. 13 indexed citations
5.
Bateman, D. Nicholas, P. H. Chapman, & M. D. Rawlins. (1983). The effects of astemizole on histamine-induced weal and flare. European Journal of Clinical Pharmacology. 25(4). 547–551. 29 indexed citations
6.
Chapman, P. H., et al.. (1981). Antipyrine clearance in psoriasis.. BMJ. 282(6257). 20–21. 11 indexed citations
7.
Chapman, P. H., M. D. Rawlins, Sam Shuster, et al.. (1981). Polymorphic 4-hydroxylation of debrisoquine in chronic discoid psoriasis. European Journal of Clinical Pharmacology. 21(3). 257–258. 1 indexed citations
8.
Chapman, P. H., et al.. (1980). Generalised tissue abnormality of aryl hydrocarbon hydroxylase in psoriasis.. BMJ. 281(6251). 1315–1316. 24 indexed citations
9.
Shuster, Sam, M. D. Rawlins, P. H. Chapman, & Sarah Rogers. (1980). Decreased epidermal aryl hydrocarbon hydroxylase and localized pustular psoriasis. British Journal of Dermatology. 103(1). 23–26. 21 indexed citations
10.
Routledge, Philip A., P. H. Chapman, D.M. Davies, & M. D. Rawlins. (1979). Factors affecting warfarin requirements. European Journal of Clinical Pharmacology. 15(5). 319–322. 64 indexed citations
11.
Shuster, Sam, P. H. Chapman, & M. D. Rawlins. (1979). Psoriasis and cancer.. BMJ. 1(6168). 941–942. 32 indexed citations
12.
Chapman, P. H., M. D. Rawlins, & Sam Shuster. (1979). ACTIVITY OF ARYL HYDROCARBON HYDROXYLASE IN PSORIATIC SKIN. The Lancet. 313(8111). 297–298. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026